Virulence factors of Candida albicans - PubMed (original) (raw)
Review
Virulence factors of Candida albicans
R A Calderone et al. Trends Microbiol. 2001 Jul.
Abstract
Candidiasis is a common infection of the skin, oral cavity and esophagus, gastrointestinal tract, vagina and vascular system of humans. Although most infections occur in patients who are immunocompromised or debilitated in some other way, the organism most often responsible for disease, Candida albicans, expresses several virulence factors that contribute to pathogenesis. These factors include host recognition biomolecules (adhesins), morphogenesis (the reversible transition between unicellular yeast cells and filamentous, growth forms), secreted aspartyl proteases and phospholipases. Additionally, 'phenotypic switching' is accompanied by changes in antigen expression, colony morphology and tissue affinities in C. albicans and several other Candida spp. Switching might provide cells with a flexibility that results in the adaptation of the organism to the hostile conditions imposed not only by the host but also by the physician treating the infection.
Similar articles
- [Virulence factors of Candida albicans].
Staniszewska M, Bondaryk M, Piłat J, Siennicka K, Magda U, Kurzatkowski W. Staniszewska M, et al. Przegl Epidemiol. 2012;66(4):629-33. Przegl Epidemiol. 2012. PMID: 23484392 Review. Polish. - Gene regulation and host adaptation mechanisms in Candida albicans.
Staib P, Wirsching S, Strauss A, Morschhäuser J. Staib P, et al. Int J Med Microbiol. 2001 May;291(2):183-8. doi: 10.1078/1438-4221-00114. Int J Med Microbiol. 2001. PMID: 11437340 Review. - Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.
Rane HS, Hardison S, Botelho C, Bernardo SM, Wormley F Jr, Lee SA. Rane HS, et al. Virulence. 2014;5(8):810-8. doi: 10.4161/21505594.2014.956648. Epub 2014 Oct 31. Virulence. 2014. PMID: 25483774 Free PMC article. - Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients.
Antony G, Saralaya V, Gopalkrishna Bhat K, Shalini Shenoy M, Shivananda PG. Antony G, et al. Rev Iberoam Micol. 2009 Sep 30;26(3):202-5. doi: 10.1016/j.riam.2009.03.001. Epub 2009 Jul 18. Rev Iberoam Micol. 2009. PMID: 19635443 - [Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects].
Hernández-Solís SE, Rueda-Gordillo F, Rojas-Herrera RA. Hernández-Solís SE, et al. Rev Iberoam Micol. 2014 Apr-Jun;31(2):137-40. doi: 10.1016/j.riam.2013.09.003. Epub 2013 Sep 23. Rev Iberoam Micol. 2014. PMID: 24071641 Spanish.
Cited by
- The progress and future of the treatment of Candida albicans infections based on nanotechnology.
Gao Y, Cao Q, Xiao Y, Wu Y, Ding L, Huang H, Li Y, Yang J, Meng L. Gao Y, et al. J Nanobiotechnology. 2024 Sep 16;22(1):568. doi: 10.1186/s12951-024-02841-6. J Nanobiotechnology. 2024. PMID: 39285480 Free PMC article. Review. - Phenotypic and Genotypic Characterization of Resistance and Virulence Markers in Candida spp. Isolated from Community-Acquired Infections in Bucharest, and the Impact of AgNPs on the Highly Resistant Isolates.
Corbu VM, Georgescu AM, Marinas IC, Pericleanu R, Mogos DV, Dumbravă AȘ, Marinescu L, Pecete I, Vassu-Dimov T, Czobor Barbu I, Csutak O, Ficai D, Gheorghe-Barbu I. Corbu VM, et al. J Fungi (Basel). 2024 Aug 9;10(8):563. doi: 10.3390/jof10080563. J Fungi (Basel). 2024. PMID: 39194889 Free PMC article. - Antifungal and antibiofilm activities of flavonoids against Candida albicans: Focus on 3,2'-dihydroxyflavone as a potential therapeutic agent.
Lee JH, Kim YG, Park I, Lee J. Lee JH, et al. Biofilm. 2024 Jul 26;8:100218. doi: 10.1016/j.bioflm.2024.100218. eCollection 2024 Dec. Biofilm. 2024. PMID: 39175909 Free PMC article. - Saps1-3 Antigens in Candida albicans: Differential Modulation Following Exposure to Soluble Proteins, Mammalian Cells, and Infection in Mice.
Barbosa PF, Gonçalves DS, Ramos LS, Mello TP, Braga-Silva LA, Pinto MR, Taborda CP, Branquinha MH, Santos ALS. Barbosa PF, et al. Infect Dis Rep. 2024 Jun 28;16(4):572-586. doi: 10.3390/idr16040043. Infect Dis Rep. 2024. PMID: 39051243 Free PMC article. - The Putative Cytochrome _b_5 Domain-Containing Protein CaDap1 Homologue Is Involved in Antifungal Drug Tolerance, Cell Wall Chitin Maintenance, and Virulence in Candida albicans.
Xu D, Wang M, Zhang X, Mao H, Xu H, Zhang B, Zeng X, Li F. Xu D, et al. J Fungi (Basel). 2024 Apr 26;10(5):316. doi: 10.3390/jof10050316. J Fungi (Basel). 2024. PMID: 38786671 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous